These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16419355)

  • 21. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Heine RJ; Holman RR; Sherwin R; Zinman B; ;
    Diabetologia; 2006 Aug; 49(8):1711-21. PubMed ID: 16802130
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B
    Diabetes Care; 2008 Jan; 31(1):173-5. PubMed ID: 18165348
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al.
    Nicolucci A; De Berardis G; Sacco M; Tognoni G
    Diabetes Care; 2007 Jun; 30(6):e57; author reply e58. PubMed ID: 17526819
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Cerasi E
    Diabetologia; 2007 Mar; 50(3):693-4. PubMed ID: 17187245
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Slama G; Balkau B; Valensi P
    Diabetologia; 2007 Jun; 50(6):1354-5; discussion 1356-7. PubMed ID: 17437078
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Coustan "Follow-up of women with previous gestational diabetes" (comment on Noctor et al. ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 2015;52:153-160).
    Noctor E; Dunne F
    Acta Diabetol; 2016 Feb; 53(1):135-6. PubMed ID: 26112415
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis of the metabolic syndrome: which definition should we use?
    Liberopoulos EN; Elisaf MS
    Hellenic J Cardiol; 2005; 46(4):258-62. PubMed ID: 16159004
    [No Abstract]   [Full Text] [Related]  

  • 28. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Petrie JR; Peters AL; Bergenstal RM; Holl RW; Fleming GA; Heinemann L
    Diabetes Care; 2017 Dec; 40(12):1614-1621. PubMed ID: 29070577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Present recommendations in type 2 diabetes treatment.
    Lebovitz HE
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():46-9. PubMed ID: 20629232
    [No Abstract]   [Full Text] [Related]  

  • 30. Congress report from the American Diabetes Association 66th Annual Scientific Sessions in Washington, USA.
    Schwarz PE; ;
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):605-10. PubMed ID: 17177145
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The American Cancer Society, American Diabetes Association, and American Heart Association joint statement on preventing cancer, cardiovascular disease, and diabetes: where are the social determinants?
    Clark AM; Raine K; Raphael D
    Diabetes Care; 2004 Dec; 27(12):3024. PubMed ID: 15562238
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B; ;
    Diabetologia; 2009 Jan; 52(1):17-30. PubMed ID: 18941734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2015 Mar; 58(3):429-42. PubMed ID: 25583541
    [No Abstract]   [Full Text] [Related]  

  • 35. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome.
    ; Punthakee Z; Goldenberg R; Katz P
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S10-S15. PubMed ID: 29650080
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics.
    Powers MA; Bardsley J; Cypress M; Duker P; Funnell MM; Fischl AH; Maryniuk MD; Siminerio L; Vivian E
    Diabetes Educ; 2015 Aug; 41(4):417-30. PubMed ID: 26047627
    [No Abstract]   [Full Text] [Related]  

  • 37. The 32nd annual meeting of the European Association for the Study of Diabetes. Leptin, insulin resistance, intrauterine malnutrition, sulfonylureas, oral agents alone and with insulin, and new pharmacological approaches to type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 1997 Aug; 20(8):1334-7. PubMed ID: 9250465
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
    Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F; ;
    Circulation; 2005 Oct; 112(17):2735-52. PubMed ID: 16157765
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS
    Circulation; 2010 Jun; 121(24):2694-701. PubMed ID: 20508178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.